ESPB vs SPSIPB for better recovery after VATS
Official title: Comparison of Ultrasound-Guided Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block for Quality of Recovery After Video-Assisted Thoracoscopic Surgery: A Randomized Double-Blind Trial
Run by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · NCT07729488 · Data updated 2026-11-12
This study tests whether an erector spinae plane block or a serratus posterior superior intercostal plane block improves recovery after video-assisted thoracoscopic surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 128 (estimated) |
| Sponsor | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital Academic / other |
| Locations | 2 sites (Diyarbakır, Outside of the US and 1 other locations) |
| Status | Recruiting |
| Started | September 16, 2026 |
| Main results expected | December 29, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT07729488 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–85 years scheduled for elective VATS under general anesthesia, ASA I–III, able to complete QoR-15, and without contraindications to regional anesthesia or the study drugs.
✕Probably not a fit
Patients with failed blocks, conversion to thoracotomy, or conditions preventing QoR-15 completion may not experience the anticipated benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind trial compares two ultrasound-guided regional anesthesia techniques—erector spinae plane block (ESPB) and serratus posterior superior intercostal plane block (SPSIPB)—in adults undergoing elective VATS. The primary outcome is the quality of recovery at 24 hours, measured by QoR-15. Secondary outcomes include pain scores, opioid consumption, time to rescue analgesia, nausea and vomiting, satisfaction, hospital stay, block safety, and perioperative hemodynamics. The study plans to enroll 128 patients and is conducted at a Turkish university hospital with a single lead sponsor. Participants are adults 18–70 (up to 85 in eligibility), ASA I–III, without contraindications to regional anesthesia or opioid analgesics, and able to complete QoR-15.
Why it matters
Potential benefit: If successful, this trial could identify the regional block that provides better early recovery and comfort after VATS, guiding analgesia planning.
How similar studies have gone: Prior studies show promising analgesic effects for both blocks in thoracic surgery, but direct comparative evidence on QoR-15 recovery remains limited, making this trial meaningful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18-85 years. * ASA physical status I-III. * Scheduled for elective VATS under general anesthesia. * Able to understand and complete the QoR-15 questionnaire. * Written informed consent provided. Exclusion Criteria: * Refusal to participate or inability to provide written informed consent. * Known allergy or contraindication to bupivacaine, paracetamol, dexketoprofen, or tramadol. * Infection at the planned block injection site. * Coagulopathy or ongoing anticoagulant therapy precluding regional anesthesia. * Severe hepatic or renal insufficiency. * Chronic opioid use or chronic pain requiring regular analgesic treatment. * Previous thoracic surgery on the operative side. * Pregnancy or breastfeeding. * Cognitive impairment, psychiatric illness, or language barrier preventing completion of the QoR-15 questionnaire. * Body mass index (BMI) \>35 kg/m². * Conversion from VATS to thoracotomy. * Failed or incomplete regional block.
Where it's running
-
Fatma Acil
Diyarbakır, Outside of the US, Turkey (Türkiye) Recruiting -
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Diyarbakır, Turkey, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Fatma Acil, M.D. — Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
- Study coordinator: Fatma Acil, M.D.
- Email: acilfatma@gmail.com
- Phone: +905337225225
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
Palatal Shield Technique to Reduce Pain and Improve Healing After Free Gingival Graft
This randomized trial tests whether a collagen sponge with a protective palatal shield made of flowable resin helps reduce pain and improve healing after free gingival graft harvest.
-
Perfusion Index to Measure Postoperative Pain in Kids After Adenotonsillectomy
This study tests whether the perfusion index can reliably reflect pain levels in children aged 1–12 after adenotonsillectomy, comparing standard care with an added glossopharyngeal nerve block.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
-
Natural Biopolymer-Based Irrigant for Root Canal Cleaning
This trial tests a chitosan nanoparticle irrigant to improve cleaning and disinfection in single-rooted teeth with asymptomatic pulp necrosis undergoing endodontic treatment.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.